文献速递糖尿病

2型糖尿病患者肺功能受损与心血管疾病发病及死亡风险:一项前瞻性队列研究

Lung Function Impairment and Risks of Incident Cardiovascular Diseases and Mortality Among People With Type 2 Diabetes: A Prospective Cohort Study.
PubMed 文献 · Diabetes Care · 2025-01-01

基于英国生物银行16242例无心血管疾病的2型糖尿病患者的前瞻性队列研究,中位随访13.9年,记录2825例心血管疾病发病和2811例死亡。FEV1、FVC、FEV1/FVC比值等肺功能指标降低与心血管疾病和全因死亡风险升高相关;与肺功能保留者相比,阻塞性通气功能障碍和限制性通气功能障碍的心血管疾病调整亚分布HR分别为1.19和1.47。将肺功能测量加入SCORE2-Diabetes模型可显著提升心血管疾病预测性能。

要点

  • 在2型糖尿病患者中,FEV1、FVC等肺功能指标降低与心血管疾病及全因死亡风险升高相关。
  • 与肺功能保留者相比,阻塞性通气功能障碍和限制性通气功能障碍患者心血管疾病风险均升高。
  • 将肺功能测量加入SCORE2-Diabetes模型可显著提升心血管疾病预测性能。

核心结论

  • 在2型糖尿病患者中,肺功能受损与心血管疾病发病风险升高和全因死亡风险升高相关。

研究设计与样本

  • 前瞻性队列研究,纳入英国生物银行16242例无心血管疾病的2型糖尿病患者。
  • 使用肺量计定义阻塞性通气功能障碍、限制性通气功能障碍和保留比值受损肺量计(PRISm),指标包括第一秒用力呼气容积(FEV1)和用力肺活量(FVC)。
  • 采用Fine-Gray亚分布风险模型估计心血管疾病风险,采用Cox比例风险模型估计全因死亡风险。

主要发现

  • 中位随访13.9年期间,记录2825例心血管疾病发病和2811例死亡。
  • 较低的FEV1、FVC、FEV1/FVC比值、FEV1占预计值百分比和FVC占预计值百分比与心血管疾病和全因死亡风险升高相关。
  • 与肺功能保留者相比,阻塞性通气功能障碍的心血管疾病调整亚分布HR为1.19(95%CI 1.05-1.35),限制性通气功能障碍为1.47(95%CI 1.33-1.65)。
  • 与对照组相比,阻塞性通气功能障碍的心血管疾病亚分布HR为1.20(95%CI 1.06-1.36),PRISm为1.43(95%CI 1.29-1.59)。
  • 上述关联在各亚组和敏感性分析中结果一致;将肺功能测量加入SCORE2-Diabetes模型可显著提升心血管疾病预测性能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Individuals with type 2 diabetes (T2D) frequently exhibit impaired lung function, potentially accelerating the onset of cardiovascular disease (CVD), although prospective studies remain limited. We aimed to explore the relationship between lung function impairment and risk of CVD and mortality within this high-risk population. RESEARCH DESIGN AND METHODS: This prospective study included 16,242 participants with T2D and free of CVD from the UK Biobank. Obstructive physiology (OP), restrictive physiology (RP), and preserved ratio impaired spirometry (PRISm) were defined using spirometry, including forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC). Fine-Gray subdistribution hazards models and Cox proportional hazards models were used to estimate risks of CVD and all-cause mortality, respectively. RESULTS: During a median follow-up of 13.9 years, 2,825 incident cases of CVD and 2,811 deaths were documented. Lower FEV1, FVC, FEV1/FVC ratio, FEV1 percent predicted, and FVC percent predicted were related to higher risks of CVD and all-cause mortality. Compared with preserved lung function, the adjusted subdistribution hazard ratios (HRs) for CVD were 1.19 (95% CI 1.05-1.35) for OP and 1.47 (95% CI 1.33-1.65) for RP. Compared with the control group, the subdistribution HRs for CVD were 1.20 (95% CI 1.06-1.36) for OP and 1.43 (95% CI 1.29-1.59) for PRISm. These associations were consistent across subgroups and sensitivity analyses. Adding lung function measurements significantly enhanced the performance of CVD prediction beyond the SCORE2-Diabetes model. CONCLUSIONS: Lung function impairment was associated with increased risks of CVD and all-cause mortality among individuals with T2D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Chen C, Huang Z, Liu L, et al. Lung Function Impairment and Risks of Incident Cardiovascular Diseases and Mortality Among People With Type 2 Diabetes: A Prospective Cohort Study. Diabetes Care. 2025. PMID: 39932813. doi:10.2337/dc24-2188

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。